Company Search:
Advanced Search
Sponsored Links
Reprocell Inc Company Snapshot
Reprocell Inc operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Reprocell Inc with three other pharmaceutical manufacturers in Asia: Gujarat Themis Biosyn Limited of India (2016 sales of 326.25 million Indian Rupees [US$4.89 million] ), Gennex Laboratories Limited of India (385.56 million Indian Rupees [US$5.78 million] ), and Natural Capsules Limited which is also based in India (620.53 million Indian Rupees [US$9.31 million] ).

Sales Analysis. During the year ended March of 2016, sales at Reprocell Inc were ¥1.07 billion (US$10.31 million). This is an increase of 88.1% versus 2015, when the company's sales were ¥567.00 million. This was the fifth consecutive year of sales increases at Reprocell Inc (and since 2011, sales have increased a total of 283%). Sales of Ips Cell Business saw an increase of 97.2% in 2016, from ¥507.18 million to ¥999.93 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Reprocell Inc
  Stock Performance Chart for Reprocell Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 468.00
(Figures in Japanese Yen)
1 Week -1.9%   13 Weeks -3.9%  
4 Weeks 10.6%   52 Weeks 6.8%  
Reprocell Inc Key Data:
  Ticker: 4978 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 1,066,374,000
(Year Ending Jan 2017).
Employees: 73
  Currency: Japanese Yen Market Cap: 27,019,929,924
  Fiscal Yr Ends: March Shares Outstanding: 57,734,893
  Share Type: Common Closely Held Shares: 7,114,328
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.